Clinical Trials Browser

Phase 1 × Colorectal Neoplasms × demcizumab × Clear all

NCT01189942 2020-09-09

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms